GENFIT Announces the Amendment of the Final Terms of the Dual Proposal to the 2025 OCEANEs Holders

In conjunction with (i) the royalty financing deal with HealthCare Royalty (HCRx) announced on January 30, 2025, and (ii) the final terms of the dual proposal to the 2025 OCEANEs holders announced on February 10, 2025, GENFIT will seek the consent of the holders of 2025 OCEANEs and proposes to amend such final terms so as to: repurchase the 2025 OCEANEs at EUR 32.75 per bond from interested bondholders, or alternativelypay a consent fee of EUR 0.90 per bond still outstanding after the upcoming bondholder me ...